Clinical Research Services
Inquiry
From bench to bedside, navigating the complexities of clinical research requires a partner with deep scientific insight and operational excellence. As a dedicated provider of cancer research solutions, Alfa Cytology offers comprehensive clinical research services designed to accelerate the development of novel diagnostics and therapeutics. Our integrated approach bridges the gap between preclinical discovery and clinical application, providing tailored support for both academic investigators and industry sponsors to bring innovative oncology treatments to market.
Overview of Clinical Research for Cancer
Designed to translate laboratory discoveries into tangible patient benefits, clinical research for cancer represents a critical phase in the therapeutic development continuum. These rigorous studies, conducted in human volunteers, aim to evaluate the safety, dosage, and efficacy of new treatments, diagnostic tools, or management strategies. Focused on generating high-quality evidence, oncology clinical research seeks to establish new standards of care, improve patient outcomes, and deepen the understanding of tumor biology, ultimately laying the foundation for regulatory approval and widespread clinical adoption.
Fig.1 Clinical trial designs to evaluate the heterogeneity of clonal evolution. (Ingles Garces, A. H., et al., 2023)
Challenges of Clinical Research for Cancer
Conducting clinical trials in oncology is fraught with unique and significant hurdles that can impede progress and delay the development of new therapies. Tumor heterogeneity, evolving regulatory standards, and the logistical complexity of multicenter trials create significant barriers to timely execution and reliable outcomes.
Complex Biology & Heterogeneity
The vast genetic and phenotypic variability of tumors, both between patients and within a single tumor, makes it difficult to predict treatment response and design universally effective protocols.
Patient Recruitment & Retention
Stringent eligibility criteria, coupled with the often-poor health status of the patient population, make enrolling and retaining a sufficient number of subjects a primary bottleneck.
Evolving Regulatory Landscape
Keeping pace with the dynamic requirements of regulatory bodies, particularly for novel modalities like cell and gene therapies, demands specialized expertise.
Rigorous Safety Monitoring
The potential for severe adverse events necessitates intensive and real-time safety surveillance to protect participants while maintaining trial integrity.
Our Services
Leveraging deep scientific expertise and a dedicated operational infrastructure, Alfa Cytology delivers fully customized clinical research services. By integrating cutting-edge science with robust project management, our solutions are designed to navigate the inherent complexities of oncology trials, ensuring efficiency, compliance, and the generation of meaningful data.
Comprehensive Clinical Research Services for Cancer
Driven by a commitment to scientific excellence, our company offers two integrated service tracks: investigator-initiated trial (IIT) services for academic and non-commercial research, and industry-sponsored trial (IST) services for pharmaceutical and biotechnology partners. Our approach to clinical research is holistic and adaptive, covering the entire trial lifecycle from initial concept to post-marketing commitments. By blending strategic oversight with meticulous execution, we support our partners to overcome challenges and to achieve their developmental milestones.
Designed to support the unique needs of academic researchers and institutions, our IIT services provide the infrastructure and expertise to translate innovative hypotheses into clinical studies. We offer flexible and scalable support that empowers investigators to conduct high-impact research while maintaining scientific independence.
Study Design & Protocol Development
Assists with hypothesis framing, endpoint selection, statistical design, and protocol writing. Includes feasibility assessment and sample size justification tailored to oncology populations.
Regulatory & Ethics Support
Prepares and submits IRB/EC dossiers, IND/IDE exemptions or cross-referencing letters, and adverse event reporting plans; manages ongoing safety reviews and protocol amendments.
Operational Trial Management
Handles site feasibility, investigator selection, contract and budget negotiation, clinical supply chain (investigational product and ancillary kits), and monitoring (on-site/remote).
Data Management & Biostatistics
Builds electronic CRFs, performs data cleaning and query resolution, executes statistical analysis plans (SAP) for interim/final analyses, and delivers clinical study reports (CSRs).
For pharmaceutical and biotechnology partners, we offer a full suite of services designed to accelerate the drug development pathway. Our integrated team manages every facet of the trial, ensuring adherence to guidelines and strategic alignment with global regulatory expectations.
By Workflow
- Phase I Clinical Trial: Focused on initial safety, tolerability, and pharmacokinetics, often in specialized patient populations. We manage dose-escalation studies with rigorous safety oversight.
- Phase II Clinical Trial: Designed to explore efficacy and further establish safety in a larger patient cohort. Our services help identify optimal dosing and patient selection biomarkers.
- Phase III Clinical Trial: Large-scale, confirmatory trials that generate the pivotal data required for regulatory approval. We provide global project management and site monitoring capabilities.
- Phase IV Clinical Trial: Post-marketing studies focused on long-term safety, real-world effectiveness, and health economics outcomes research to support ongoing market access.
By Management
Medical & Clinical Strategy Services
Developing phase-appropriate development plans, target product profiles (TPP), and clinical trial designs aligned with regulatory expectations and competitive landscapes. Includes early asset positioning, dose‑finding strategies, and biomarker integration plans tailored to specific oncology indications.
IND/NDA/BLA Application Strategy Services
Preparing and submitting investigational new drug (IND), new drug application (NDA), or biologics license application (BLA) packages, including pre-IND meetings, agency correspondence, and responses to information requests. Ensures complete, inspection‑ready dossiers for global health authorities.
Site Management & Patient Recruitment Services
Identifying and qualifying oncology sites, negotiating budgets and contracts, and implementing tailored recruitment/retention strategies for molecularly defined patient populations. Includes feasibility assessments, start‑up coordination, and real‑time enrollment tracking with adaptive contingency planning.
Data Management & Statistical Analysis Services
Building and validating electronic case report forms (eCRFs), performing data cleaning and locking, and executing statistical analysis plans (SAP) with interim/final reporting. Applies CDISC standards (SDTM/ADaM) and provides independent biostatistical oversight for pivotal trials.
Medical Monitoring Services
Providing 24/7 safety oversight, eligibility review, protocol deviation management, and real-time medical guidance to investigators and site staff during trial conduct. Includes centralized medical review of adverse events, concomitant medications, and laboratory trends.
Quality Management Services
Implementing risk-based quality management systems (RBQM), conducting internal audits, vendor qualifications, and ensuring CAPA and inspection readiness throughout the trial lifecycle. Develops quality manuals, SOPs, and training plans tailored to oncology trial complexity.
Medical Writing Services
Authoring clinical study protocols, investigator brochures (IB), informed consent forms (ICF), clinical study reports (CSR), and submission-ready summary documents. Maintains compliance and consistent terminology across all clinical and regulatory writings. Also provides targeted writing support for responses to agency questions, briefing books, and publication manuscripts.
Safety & Pharmacovigilance Services
Collecting, processing, and reporting adverse events (AEs) and serious adverse events (SAEs) in compliance with guidelines, including expedited reporting. Manages DSMB/DMC support, SUSAR handling, and periodic safety update reports (PSURs). Additionally, performs signal detection and benefit-risk assessments across the trial lifecycle.
Project Management Services
Serving as the central hub for trial execution, this service ensures on-time and within-budget delivery by integrating all functional workstreams, managing complex timelines, and implementing proactive risk mitigation to navigate the operational challenges of oncology drug development.
Post-Marketing Study Services
Designing and executing Phase IV studies, registries, and real-world evidence (RWE) collections to support label expansion, safety surveillance, and health technology assessments. Includes long‑term follow‑up, comparator arm management, and regulatory post‑commitment fulfillment.
Disease Areas of Focus
Bringing specialized knowledge to the forefront of every project, our expertise spans a broad spectrum of oncologic indications. From common solid tumors like breast, lung, colorectal, and prostate cancers to complex hematologic malignancies and rare diseases, we provide tailored clinical research solutions. Each clinical program is customized to the specific histological and molecular profile of the target disease, ensuring that the research strategy reflects the current standard of care and the most promising therapeutic trends.
Why Choose Us?
- Deep Scientific Expertise: Profound knowledge in oncology and translational medicine, enabling a grasp of the nuances of your science and supporting the specialized experimental design.
- Operational Excellence: Consistent delivery on time and within budget through robust project management, experienced clinical operations teams, and a global network of investigative sites.
- Integrated Solutions: A comprehensive, one-stop service model from initial IIT strategy to final regulatory documentation, which can reduce complexity and streamline communication.
- Collaborative Partnership: A philosophy of operating as an extension of your team, offering transparent communication, strategic flexibility, and a shared commitment to advancing cancer therapy.
Contact Us
From early-phase strategy to post-marketing surveillance, Alfa Cytology's comprehensive clinical research services are designed to support your oncology program at every stage. We are committed to providing the scientific rigor and operational precision required to navigate the complexities of drug development. To discuss how we can support your clinical trial, please
contact our team.
Reference
- Ingles Garces, Alvaro H et al. "Clinical trial designs for evaluating and exploiting cancer evolution." Cancer treatment reviews 118 (2023): 102583.
For research use only.
Related Services
